Command Palette

Search for a command to run...

BALAXI
43.55(+0.18%)
1W: -0.39%

Balaxi Pharmaceuticals Peer Comparison

Snapshot Summary

Balaxi Pharmaceuticals Ltd. shows significant weaknesses in growth, profitability, and valuation metrics compared to its peers. Its negative revenue growth and return metrics indicate financial distress, making it a sector laggard in the trading industry. In contrast, companies like Adani Enterprises and Redington are strong performers with solid growth and profitability.

  • Balaxi Pharmaceuticals has the lowest revenue growth YoY and 3-Year among peers.
  • It also demonstrates negative ROE and ROA, indicating poor profitability.
  • Adani Enterprises leads in ROE and EPS growth, while Balaxi is the weakest in all financial aspects.
  • Adani Enterprises Ltd.: Leads in growth and profitability with strong EPS and ROE.
  • Redington Ltd.: Well-rounded performance with solid ROE and manageable debt levels.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
BALAXI--0.002.31%0.09
ADANIENT₹2,283.00₹2,63,499.29Cr43.5311.81%1.45
REDINGTON₹243.85₹19,063.56Cr13.2023.63%0.37
CPPLUS₹1,246.40₹14,610.54Cr107.9941.16%0.46
CELLO₹535.15₹11,820.66Cr120.1543.92%0.32
HONASA₹298.95₹9,721.38Cr151.708.99%-
MMTC₹62.18₹9,327.00Cr134.156.90%-

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.